Cold agglutinin disease by NovelMed Therapeutics for Acquired (Autoimmune) Hemolytic Anemia: Likelihood of Approval
Cold agglutinin diseaseis under clinical development by NovelMed Therapeutics and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia.
Cold agglutinin diseaseis under clinical development by NovelMed Therapeutics and currently in Phase I for Acquired (Autoimmune) Hemolytic Anemia.
What's Your Reaction?
